Cocrystal Pharma, Inc. (COCP) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.34M | -1.74M | -1.55M | -2.15M | -2.94M | -3.16M | -5.12M | -3.7M | -4.5M | -3.33M | -2.68M | -5.55M |
| Operating CF Margin % | -1040% | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 20.38% | 45.06% | 69.77% | 41.74% | 34.73% | 4.99% | -91.09% | 33.33% | -44.74% | 32.03% | 69.9% | -48.98% |
| Net Income | -2.3M | -2.43M | -2.05M | -2.06M | -2.3M | -3.27M | -4.94M | -5.34M | -3.96M | -4.46M | -4.17M | -4.17M |
| Depreciation & Amortization | 12K | 13K | 13K | 21K | 25K | 101K | 277K | 33K | 35K | -1.7M | 108K | 155K |
| Stock-Based Compensation | 84K | 56K | 0 | 84K | 82K | 85K | 253K | 148K | 157K | 158K | 173K | 179K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -2K | 0 | -142K | -148K | 0 | -68K | -69K | -73K | 0 | 1.74M | -57K | -115K |
| Working Capital Changes | -135K | 621K | 629.35K | -57K | -745K | -12K | -645K | 1.54M | -739K | 945K | 1.26M | -1.6M |
| Change in Receivables | -55K | 740K | 1.17M | -198K | -229K | -563K | 425K | -74K | -113K | -340K | 212K | 194K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 10K | 0 | -349.79K | 0 | -505K | 0 | 0 | 0 | -883K | 0 | 0 | 0 |
| Cash from Investing | 0 | 0 | -12.56K | 0 | 0 | 0 | 0 | 0 | -8K | -59K | 0 | -14K |
| Capital Expenditures | 0 | 0 | -12.56K | 0 | 0 | 0 | 0 | 0 | -8K | -59K | 0 | -14K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 1.03M | 4.54M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 5.21M | 4.54M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -4.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4M |
| Net Change in Cash | -2.34M | -704K | 2.96M | -2.15M | -2.94M | -3.16M | -5.12M | -3.7M | -4.51M | -3.38M | -2.68M | -1.56M |
| Free Cash Flow | -2.34M | -1.74M | -1.56M | -2.15M | -2.94M | -3.16M | -5.12M | -3.7M | -4.51M | -3.38M | -2.68M | -5.56M |
| FCF Margin % | -1040% | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 20.38% | 45.06% | 69.53% | 41.74% | 34.85% | 6.65% | -91.09% | 33.5% | -42.93% | 30.99% | 70.11% | -49.36% |
| FCF per Share | -0.17 | -0.15 | -0.14 | -0.21 | -0.29 | -0.31 | -0.50 | -0.36 | -0.44 | -0.33 | -0.26 | -0.55 |
| FCF Conversion (FCF/Net Income) | 1.02x | 0.72x | 0.76x | 1.05x | 1.28x | 0.97x | 1.04x | 0.69x | 1.14x | 0.75x | 0.64x | 1.33x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |